Testing for arthritis typically involves a combination of a physical exam, blood tests, imaging, and sometimes a sample of fluid drawn from the joint itself. No single test confirms every type of arthritis, because “arthritis” is an umbrella term covering more than 100 conditions, from osteoarthritis to rheumatoid arthritis to gout. The specific combination of tests your doctor orders depends on which type they suspect.
What Happens During the Physical Exam
The diagnostic process starts with your doctor examining your joints directly. They’ll press on them to check for swelling, warmth, and tenderness, and they’ll ask you to bend and move to see how much range of motion you have. They’ll also watch how you walk and carry out basic movements. In some cases, they’ll look for visible clues beyond the joints themselves: a skin rash might point toward psoriatic arthritis, firm lumps (called nodules) under the skin can suggest rheumatoid arthritis, and sounds in the lungs may indicate inflammation has spread beyond the joints.
Your doctor will also ask about the pattern of your symptoms. Whether the pain is in one joint or many, whether it’s symmetrical (both knees, both wrists), whether it’s worse in the morning or after activity, and how long the stiffness lasts all help narrow down the type of arthritis before any lab work is ordered.
Blood Tests for Inflammatory Arthritis
Blood work is most useful for detecting inflammatory types of arthritis, especially rheumatoid arthritis. The two key markers are rheumatoid factor (RF) and anti-CCP antibodies. Anti-CCP is the more precise test: in early inflammatory arthritis, it correctly identifies rheumatoid arthritis 90 to 97% of the time when positive, compared to 80 to 90% for RF. Using both tests together catches more cases than either one alone, because some people test positive on one but not the other.
Doctors also check general inflammation markers in the blood. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) both rise when inflammation is active in the body. These markers can increase dramatically during flares, sometimes more than 100-fold above normal levels. They don’t point to a specific type of arthritis on their own, but they help confirm that an inflammatory process is happening and are used to track how active the disease is over time.
For rheumatoid arthritis specifically, doctors use a formal scoring system developed by the American College of Rheumatology and the European Alliance of Associations for Rheumatology. It assigns points across four categories: how many and which joints are affected, blood test results for RF and anti-CCP, whether symptoms have lasted longer than six weeks, and whether CRP or ESR levels are elevated. A score above a certain threshold supports a classification of rheumatoid arthritis.
What X-Rays and Other Imaging Reveal
X-rays are the standard starting point for evaluating joint damage, particularly in osteoarthritis. Doctors look for four main signs: bone spurs forming at the joint edges, narrowing of the space between bones (which means cartilage is wearing away), hardening of the bone just beneath the cartilage, and changes in the shape of the bone ends. These findings are graded on a 0 to 4 scale. Grade 0 means no arthritis is visible. Grade 1 shows only questionable changes. By Grade 3, there’s definite joint space narrowing with moderate bone spurs. Grade 4 shows severe narrowing, large bone spurs, and clear deformity of the bone.
The limitation of X-rays is that they show damage only after it has already occurred. For catching arthritis earlier, ultrasound and MRI are more sensitive. Ultrasound can detect inflammation in the joint lining before bone damage starts, and it has practical advantages: it can scan multiple joints quickly and is more comfortable than lying still inside an MRI machine. MRI provides the most detailed view of soft tissue, cartilage, and early bone erosions, making it especially useful when rheumatoid arthritis is suspected but X-rays still look normal.
Joint Fluid Analysis
When a joint is noticeably swollen, your doctor may use a needle to draw out a small sample of the fluid inside it. This procedure, called arthrocentesis, is one of the most direct ways to figure out what’s causing the problem. The fluid’s appearance and lab results tell different stories depending on the type of arthritis.
Normal joint fluid is clear or straw-colored and contains very few white blood cells. In osteoarthritis, the fluid stays relatively clear with low cell counts, because the problem is mechanical wear rather than immune-driven inflammation. In inflammatory arthritis like rheumatoid arthritis, the fluid turns yellow and contains between 2,000 and 50,000 white blood cells per microliter. If infection is causing the joint inflammation, the fluid becomes cloudy or opaque, with white blood cell counts above 50,000.
Joint fluid analysis is also the definitive test for gout and a related condition called pseudogout. Under a special microscope, gout shows needle-shaped crystals, while pseudogout shows diamond-shaped crystals. No blood test or imaging study can confirm these diagnoses as reliably as seeing the crystals directly.
Testing for Psoriatic Arthritis
Psoriatic arthritis requires its own diagnostic approach because it overlaps with other types. Doctors use a set of criteria that looks at five factors: whether you have current psoriasis (or a personal or family history of it), whether your nails show pitting or lifting from the nail bed, whether your rheumatoid factor test is negative, whether you have dactylitis (a whole finger or toe swollen into a “sausage” shape), and whether X-rays show new bone forming near the joints. Having inflammatory joint disease plus at least three of these five features points strongly toward psoriatic arthritis.
Multi-Biomarker Testing
A newer blood test measures 12 different proteins related to rheumatoid arthritis activity and combines them into a single score on a scale of 1 to 100. Scores below 30 indicate low disease activity, 30 to 44 is moderate, and above 44 is high. This test is commercially available in the United States and is primarily used to monitor how well treatment is working rather than to make an initial diagnosis. In studies, it was better at predicting which patients would develop joint damage over time than traditional inflammation markers alone, making it useful for guiding treatment decisions after diagnosis.
Why Early Testing Matters
Getting tested promptly makes a real difference in outcomes, especially for inflammatory types of arthritis where joint damage can begin within months. Yet delays are common. Only about 22% of people with rheumatic diseases see a rheumatologist within 12 weeks of their first symptoms. The median total delay from symptom onset to specialist evaluation is around 24 months, with the most common reason being incomplete assessment at the primary care level. If your primary care doctor isn’t sure what’s causing your joint symptoms, asking specifically for a rheumatology referral can shorten that timeline significantly.
For rheumatoid arthritis in particular, the formal classification criteria include a six-week threshold for symptom duration. This means doctors can begin the diagnostic workup well before the disease has had time to cause permanent damage, as long as you’re seen early enough. The combination of a thorough physical exam, targeted blood work, and imaging when needed gives doctors the tools to identify the specific type of arthritis and start the right treatment.